Zobrazeno 1 - 10
of 852
pro vyhledávání: '"Jing Zhao"'
Autor:
Minjiang Chen, Yan Xu, Jing Zhao, Xiaoyan Liu, Xiangning Liu, Dongming Zhang, Yuequan Shi, Li Zhang, Wei Zhong, Mengzhao Wang
Publikováno v:
Clinical Lung Cancer. 24:278-286
Autor:
Hong Liu, Li Ma, Xu Wang, Xinzhong Chang, Qi Yu, Qingfeng Huang, Chunfang Hao, Jun Liu, Jing Zhao, Shufen Li, Zhongsheng Tong, Yehui Shi, Ning Lu, Weipeng Zhao, Tong Wang, Xuchen Cao, Chen Wang, Juntian Liu, Ying Zhao, Lina Zhang, Baoliang Guo, Xin Wang, Xu Di, Chunhui Gao, Zongzhan Liu, Shuo Sun, Linwei Li
Publikováno v:
Cancer Research. 83:P1-12
Objective: Pyrotinib, an oral irreversible pan-HER receptor tyrosine kinase inhibitor, showed promising efficacy and manageable safety profiles in the treatment of HER-2 positive breast cancer. Diarrhea is the most common adverse event associated wit
Autor:
Yinping Wang, Gang Wang, Xin Hong, Jing Zhao, Dan Wu, Lin Chen, Xiaoli Liu, Deyu Kong, Qichao Huang, Jinliang Xing, Nan Wang, Yilin Zhao
Publikováno v:
Cancer Science. 114:1464-1478
Autor:
Hongbo, Yang, Vamsi, Bollu, Stephen, Lim, Mimi, Tesfaye, Anand A, Dalal, Angela, Lax, Sakshi, Sethi, Jing, Zhao
Publikováno v:
Leukemia & Lymphoma. 64:339-348
Chimeric antigen receptor T-cell (CAR-T) infusion settings may impact healthcare resource use (HRU) and reimbursement amounts. Adults with diffuse large B-cell lymphoma receiving CAR-T therapy were identified from the Centers for MedicareMedicaid Ser
Autor:
Jingjiang Lai, Xiaoli Zhuo, Ke Yin, Fengxian Jiang, Lei Liu, Xiaoying Xu, Hongjing Liu, Jingliang Wang, Jing Zhao, Wei Xu, Shuping Yang, Honglin Guo, Xiaotian Yuan, Xiaoyan Lin, Fanghua Qi, Guobin Fu
Publikováno v:
Anti-Cancer Drugs. 34:747-762
Pyrotinib is a novel epidermal growth factor receptor/human epidermal growth factor receptor-2 (HER2) tyrosine kinase inhibitor that exhibited clinical efficacy in patients with HER2-positive breast cancer and HER2-mutant/amplified lung cancer. Howev
Autor:
Qing Sun, Xuemei Qin, Jing Zhao, Tianle Gao, Yinwei Xu, Guohui Chen, Guangping Bai, Zhiqiang Guo, Jian Liu
Publikováno v:
Apoptosis. 28:247-262
Cuproptosis is a novel, distinct form of regulated cell death. However, little is known about the role of cuproptosis-related lncRNAs (CRlncRNAs) in head and neck squamous cell carcinoma (HNSCC). This study aimed to identify a CRlncRNAs signature, ex
Autor:
Wei Gu, Yubin Wang, Ran Xu, Jiamin Li, Jingjie Jin, Jing Zhao, Yang Chen, Yuanzhi Lu, Gong Zhang
Publikováno v:
Frontiers in Oncology. 13
Stable internal reference genes are crucial for quantitative real-time PCR (qRT-PCR) analyses in lung cancer studies. Widely used reference genes are mostly chosen by intuition or from pan-cancer transcriptome data and lack experimental validation by
Autor:
Wen You, Xinyu Liu, Hao Tang, Bo Lu, Qingyang Zhou, Yue Li, Minjiang Chen, Jing Zhao, Yan Xu, Mengzhao Wang, Jiaming Qian, Bei Tan
Publikováno v:
Journal of Immunotherapy.
Publikováno v:
Molecular Medicine Reports. 27
Autor:
Jing Zhao, Wei Xu, Xiaoli Zhuo, Lei Liu, Junlei Zhang, Fengxian Jiang, Yanru Shen, Yan Lei, Dongsheng Hou, Xiaoyan Lin, Cuiyan Wang, Guobin Fu
Publikováno v:
The Oncologist.
Triple-negative breast cancers (TNBC) represent a pathological subtype of breast cancer, which are characterized by strong invasiveness, high metastasis rate, low survival rate, and poor prognosis, especially in patients who have developed resistance